Guggenheim analyst Yatin Suneja upgraded Acadia Pharmaceuticals to Buy from Neutral with a $22 price target.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ACAD:
Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
The Fly
Acadia Pharmaceuticals upgraded to Buy from Neutral at Guggenheim
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
